|Daily Range||$69.29 - $71.79|
|52-Week Range||$31.05 - $111.46|
|Dividend (Yield)||$0.00 (0.0%)|
|Average Daily Volume||384,120|
|Current FY EPS||-$4.64|
GW Pharmaceuticals Plc (ADR) (GWPH) Description
GW Pharmaceuticals Plc - American Depositary Shares Website: http://www.gwpharm.com/
News & Commentary
Isis Pharmaceuticals, PTC Therapeutics, and GW Pharmaceuticals all expect 2015 to be a pivotal year in their drive toward becoming commercially viable entities. Should investors jump in before the catalysts spark?
Diabetes affects more than 29 million Americans and can lead to a number of serious complications. However, this currently illegal drug could provide a new pathway for diabetics to achieve better glycemic balance.
Diabetes affects 29.1 million people in the United States, and is a dangerous long-term disease in its own right. This latest study, however, could add another aspect for diabetics to worry about.
Consensus? We don't need no stinking consensus!
What makes a good healthcare stock? In this episode, we discuss what investors should look for when evaluating healthcare stocks, including one company to watch, and one to avoid.
American Cannabis Company, A Delaware Corporation, Joins The List Of At Least 46 Other Marijuana Stocks
A recent study showed that cannabinoids could be an effective treatment in slowing the progression of a deadly disease which is expected to see diagnoses grow by 176% between now and 2050.
Two Motley Fool analysts share there competing views on whether or not big drugmakers should jump into the medical marijuana market.